In times of crisis, it is advantageous for people with rare diseases to receive care in highly specialized centers. This is underlined by an MHH study. It shows that the people with the autoimmune diseases NMOSD and MOGAD cared for there came through the COVID 19 pandemic well.
14.03.2023
For people with chronic diseases, the COVID-19 pandemic was particularly challenging: many were worried and uncertain about the risk of infection, vaccination, and continuing their (immunosuppressive) therapy. ...